New Clinical Trials: February 2024

The below are the clinical trials posted for the first time in February 2024.

Phase 4:

1. The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
2. Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome
3. Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
4. Liposomal Bupivacaine vs Bupivacaine With Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
5. Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks
6. The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer
7. Plan Development for Giving Teclistamab in the Outpatient Setting
8. A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or SΓ©zary Syndrome Previously Treated With Systemic Therapy
9. Stellate Ganglion Block
10. A Study of Camrelizumab Combined With Chemotherapy Β± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
11. A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
12. Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Phase 3:

1. Early Neutropenic Fever De-escalation of Antibiotics Study
2. A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With KeytrudaΒ®(EU/US) in Participants With IV nqNSCLC
3. a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients
4. A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma
5. Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
6. A Study to Investigate Efficacy & Safety of INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
7. Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
8. Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
9. Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVACΒ®) in Women Living With HIV Aged 15-25 Years
10. A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
11. Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer
12. Stockholm Mammography Risk Stratified Trial
13. Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
14. Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
15. A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
16. A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy
17. Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.
18. A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma
19. The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma
20. A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations
21. VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3)
22. Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
23. Individualized Elective Neck Irradiation in NPC Patients
24. PD-1 Inhibitor Plus Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
25. Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma
26. A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
27. Neoadjuvant Immunochemotherapy for LAOSCC
28. Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.
29. PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
30. A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
31. Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
32. Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naΓ―ve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
33. A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies
34. A Phase IIII Study of AL8326 in Small Cell Lung Cancer

Phase 2-3:

1. Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations
2. Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy
3. TYK2 Inhibition in Paradoxical Psoriasis
4. Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
5. Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
6. Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
7. Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
8. Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
9. Sacituzumab Govitecan in Metastatic Colorectal Cancer
10. A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2:

1. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
2. Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
3. A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer
4. Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients
5. Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
6. PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
7. Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI
8. Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
9. Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer
10. Second-line Treatment of Metastatic Colorectal Cancer
11. PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
12. Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction
13. Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
14. Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors
15. Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
16. A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood
17. Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
18. Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
19. A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
20. Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
21. HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma
22. Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)
23. Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
24. Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: A Pilot Randomized Controlled Trial
25. A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
26. mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
27. A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies
28. Sequencing Antibody Drug Conjugates in ER+/HER2 LOW MBC
29. Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
30. Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
31. Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
32. Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer
33. A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
34. SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia
35. A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)
36. Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
37. Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
38. Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
39. Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
40. Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
41. Clinical Trial for Advanced or Metastatic Pancreatic Cancer
42. A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC
43. The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
44. Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC
45. Neoadjuvant PSMA-RLT in Oligometastatic PCa
46. Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer
47. Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial
48. NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer
49. The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma
50. Repositioning Immunotherapy in VetArans With Lung Cancer
51. An Open, Single-arm, Multicenter, Prospective Phase II Study of Fuquinitinib Combined With Tegafur Gimeracil Oteracil in the Third-line Treatment of Patients With Advanced Metastatic CRC
52. Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
53. A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer
54. Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study
55. Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer
56. A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer
57. FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
58. A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients
59. Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
60. Phase II Trial of Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
61. Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
62. The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
63. Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
64. GVMΒ±R in Patients With Relapsed or Refractory Aggressive NHL.
65. HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
66. Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
67. Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery
68. A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
69. Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
70. Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
71. Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
72. A Biomarker-Guided Phase 2 Study of DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) Extended-Release Tablets
73. A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naΓ―ve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
74. Cannabis for Palliative Care in Cancer
75. A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab（AK104） for Newly Diagnosed Local Advanced Cervical Cancer
76. The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma
77. A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
78. Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program
79. A Study of IBI363 in Subjects With Advanced Solid Malignancies
80. Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer With EGFR Mutation and PD-L1 Positive Expression
81. A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib
82. Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma
83. MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
84. Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
85. Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma
86. Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade
87. Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
88. Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM
89. Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
90. HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma
91. A Study of T-DXd in Patients With Selected HER2-overexpressing Tumors
92. Botensilimab and Balstilimab Optimization in Colorectal Cancer
93. DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)
94. Topical Anti-Androgens in Pilonidal Sinus Disease
95. Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial
96. Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
97. Phase II Study of Elranatamab as Single Agent for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
98. A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
99. Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
100. Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer
101. First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
102. Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC
103. Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy
104. Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy
105. Phase 1-2:
106. A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
107. Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients
108. A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
109. A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
110. An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia

Phase 1:

1. An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
2. MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

Phase Not Applicable:

1. A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
2. Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)
3. Physical Activity Monitoring in Myasthenia Gravis
4. In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor
5. Fertility and Pregnancy After Avelumab Treatment
6. Comparsion Between Intravenous Infusion of Ketofol and Inhalational Anasthetics in Abdominal Cancer Surgeries for Post Operative Analgesia
7. Cryotherapy & Oxaliplatin
8. Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial
9. The Importance of Inflammatory Markers Calculated From Preoperative and Postoperative Peripheral Blood Results in the Diagnosis and Treatment of Patients Operated for Hydatid Cyst of the Lung (Lung Echinococcus Granulosus)
10. Biomechanical and Metabolic Assessment Pre and Post Vertebroplasty in Multiple Myeloma Patients With Vertebral Collapse
11. LI-TASTE Study: Light for Taste
12. Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
13. Probiotc Lactobacillus Crispatus-M247 (CrispactΒ®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses
14. Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling
15. Prognostic Significance of ctDNA in HL
16. Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma
17. EUS Guided Drainage of Post Pancreatitis Pancreatic Fluid Collection
18. The AMARA (As Much As Reasonable Acceptable) Study
19. Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling
20. Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)
21. Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer Patients
22. Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery
23. Randomized Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies
24. Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)
25. Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement
26. D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study
27. Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design
28. Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
29. Psychological Factors Influencing Cancer Post-traumatic Growth
30. Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
31. Intraoperative Imaging of Lymph Nodes
32. Early Diagnosis of Gastric Cancer Cachexia
33. Virtual Reality During Colonoscopy Procedures
34. Prospective Trial: Myocardial Injury After Noncardiac Surgery (MINS) Following Radical Prostatectomy
35. Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy
36. Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.
37. Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions
38. Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LVΒ± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer
39. Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale
40. Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
41. Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data
42. AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
43. Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
44. MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer
45. Iron-deficiency Anaemia and Its Impact on Recovery After Colorectal Cancer Surgery
46. 177Lu-LNC1011 in Patients With Metastatic Castration-resistant Prostate Cancer
47. Proactive Outreach With FIT
48. AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
49. NODE (groiN ultrasOunD cancEr)
50. ICOPE Program Feasibility in the Management of Myeloma Patients
51. Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
52. ACS Community Access to Resources Education and Support
53. Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer
54. Impact of Quality of Life in the Patients With Sleep Disturbance From Low Anterior Resection Syndrome in Advanced Rectal Cancer Patients
55. FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
56. Lung EpiCheck Biomarkers Development Study
57. Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases
58. Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy
59. National Robotics-Assisted Radical Prostatectomy Database
60. A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
61. Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
62. The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
63. The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients
64. BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE
65. Immunotherapy for Hepatocellular Carcinoma
66. Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis: A Randomized Controlled Trial
67. BC Risk Assessment Before Top Surgery
68. Optimizing Surgical Decisions in Young Adults With Breast Cancer
69. The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.
70. Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
71. Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit
72. UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
73. Korean Registry of Non-Small Cell Lung Cancer Patients With EGFR Mutation
74. Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment
75. Psychosexual Educational Partners Program (PEPP)
76. The Effect of an Online ACT Intervention on Meaning-Making Process in Cancer Patients Following Hematopoietic Cell Transplantation
77. Anxiety & Depression in Thyroid Cancer Patients
78. Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer
79. Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis
80. Prospective Observational Study of Diffuse Large-cell B Lymphoma
81. RAT-HEMATO : Return to Work After Malignant Hemopathy
82. Clinical Study on the Evaluation of the Efficacy of Cervical Cancer
83. Effectiveness of an Aerobic Exercise Program in Cancer Survivors.
84. Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer
85. OncoSweep Cancer Spotlight and Spectrum Product Line
86. Evaluation of the Cancer Tracking System (CATSystem)
87. Visually Impaired Women Model-based Cancer Education and Breast Self-examination
88. The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
89. Metastatic Melanoma Patients on Immunotherapy With Nutritive Intervention Based on Mediterranean Diet
90. Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment
91. GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
92. Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
93. ctDNA for Early Detection of Recurrence in Melanoma
94. LUNGevity: Lung Cancer Stigma Community Based Participatory Research
95. MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients
96. Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine
97. The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
98. Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis: Prospective Observational Study
99. Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
100. An Investigation Into Dielectric Assessment of Permittivity and Cancer in Human Using a Novel Electrical Capacitance Tomography Scanner
101. Detection of Cancer in Breath Samples by Trained Detection Dogs
102. Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
103. Prophylactic Double Thermal Ablation and Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps: A Randomized Controlled Trial
104. PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
105. Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer
106. Exercise and Nutrition Intervention in Ovarian Cancer
107. Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery
108. Stress-reducing Intervention in Urothelial Carcinoma
109. Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
110. Feasibility of Cryobiopsy From the Bile Duct - CRYLEO
111. Influencing Factors for Physical Activity in People With Head and Neck Cancer
112. Omission of Axillary Surgery in Breast Cancer Patients
113. The Effect of Mobile Health Application on Posttraumatic Growth in Women Diagnosed With Breast Cancer
114. Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood
115. Generation of Lung Tumor Organoids From Patients Undergoing Diagnostic Bronchoscopy
116. HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
117. High Impact Training to Patients With Prostate Cancer and Bone Metastases
118. The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
119. Myasthenia Gravis Registry in China
120. Comparing Radiotherapy Immobilization Systems for Anxious HNC Patients
121. A Study to Evaluate Efficacy and Safety of Hydeal CystΒ® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
122. Volumetric Changes in Large Cystic Lesions Using Active Decompression and Distraction Sugosteogenesis vs Passive Decompression
123. The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes
124. Focal Therapy for Localized Prostate Cancer
125. Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer
126. Personalized Care Pathways for Bowel Symptoms in Rectal Cancer Patients
127. INTER-PATHOLOGIST READER STUDY
128. Effect of ICCAUT Strategy on Postoperative Urinary Dysfunction After Radical Rectal Cancer Surgery
129. The LINFUΒ® U.S. Registry for the in the General Population Without Risk Factors
130. Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas
131. European Myeloma Network (EMN) Sample Project
132. Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study
133. Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence
134. Targeted Navigation in Hepatocellular Carcinoma (HCC)
135. Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer
136. Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
137. Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery
138. Ultrasound Guided Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block vs Type 2 Pectoral Nerve Block in Analgesia for Breast Cancer Surgery
139. Medical YOga dUring CANcer Treatment in a Digital or Physical Setting - a PREFERensbased Study
140. Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
141. Interactive Telehealth Intervention to Increase Longitudinal Adherence to Repeat Faecal Immunochemical Test Screening
142. The ONCOCAMP Study
143. The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
144. Intermittent Oro-esophageal Tube Feeding in Late Dysphagia for Nasopharyngeal Carcinoma
145. The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer
146. Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis
147. Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain
148. Active Surveillance for Low-risk Papillary Thyroid Carcinoma
149. Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions
150. Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M)
151. Optimization of Radiation Protection Through Genomic Analyses
152. Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )
153. A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
154. The Effect of Late-evening Snacks on Patients With Primary Hepatocellular Carcinoma After Hepatectomy
155. Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a Study Protocol
156. Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
157. INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy
158. Uveal Melanoma - Comparative Study
159. Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia
160. Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)
161. A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score
162. The LINFUΒ® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
163. The LINFUΒ® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
164. Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
165. BostonGene and Exigent Genomic INsight Study
166. Tumor Microenvironment in Ovarian Cancer
167. AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma
168. Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
169. MRI Guided SIB Radiotherapy in Neoadjuvant Therapy for Advanced Rectal Cancer
170. Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process
171. Cardiac Rehabilitation for Breast Cancer Survivors
172. Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer
173. Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity
174. Two Schemes Response in Multiple Myeloma
175. Molecular Analysis for Precision Surgery in Thyroid Cancer Trial
176. Postoperative Morbidity and Mortality After Gastric Cancer Surgery
177. Centralized Screening Unit (CSU) at Montefiore-Einstein
178. HPV DNA Self-sampling in a General Practitioner's Office.
179. Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
180. Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
181. First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours
182. Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
183. Early-Onset Colorectal Cancer Recurrence
184. Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study
185. 68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
186. Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study
187. Find HDV and Determine Its Status in Turkey
188. FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients
189. Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma
190. Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
191. Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
192. LAG3 Expression in Triple Negative Breast Cancer
193. Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy
194. Effects of Exercise Training in Survivors of Lymphoma
195. Comprehensive HHT Outcomes Registry of the United States (CHORUS)
196. Intermittent Oro-esophageal Tube Feeding in Delayed Dysphagia for Nasopharyngeal Carcinoma
197. a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
198. Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer
199. AIOCC Italian Registry on Head and Neck Carcinomas
200. Oral Microbiome Diagnostics of Lung Cancer
201. Pancreatic Cancer Initial Detection Via Liquid Biopsy
202. The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
203. Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2
204. The Microbrect-FFC Study
205. Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.
206. Efficacy and Safety of NSCLC Patients With/Without Adjuvant Immunotherapy Who Have Achieved pCR After Neoadjuvant Immunotherapy
207. Real-world Ruxolitinib Experience in PV
208. H. Pylori Screen-and-treat Study in a Population of Young Adults
209. A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL
210. AI Determine Malignancy of GGO on Chest CT
211. Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy
212. Feasibility of a Colorectal Cancer Screening Web App in Primary Care Patients
213. Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision
214. Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
215. Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
216. The Effect of Cervical Cancer Awareness Education Based on Mobile Application
217. Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients
218. Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
219. Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
220. Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
221. Evidence Development in Cancer Treatment - Real World: PREDiCTrw
222. Pelvic Exenteration and Laterally Extended Pelvic Resection
223. Comparison of Apixaban Versus Enoxaparin
224. Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
225. Novel Robotic Prostatectomy Technique for Early Urinary Continence
226. Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery
227. Burden of Disease and Living Situation in Desmoid Patients
228. NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
229. Physical Exercise Benefits for Cancer Patients
230. Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
231. Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
232. Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.
233. Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer
234. Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence
235. Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
236. Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)
237. European Rare Blood Disorders Platform (ENROL)
238. Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision
239. A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
240. Longterm Effectiveness of Artificial Intelligence-assisted Colonoscopy on Adenoma Recurrence
241. Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
242. Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
243. Umbrella Study for Single Patient Treatments in Oncology
244. Palmaris Longus Muscle and Dupuytren
245. Short Term Surgical Outcomes of Anatomical Versus Non Anatomical Laparoscopic Liver Resection for Liver Tumors
246. Clinical Evaluation, Motor Performance and Quality of Life in Patients Affected by Soft Tissue Sarcomas, Undergoing Surgical Treatment: Observational Study
247. Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
248. Development of a Culturally Tailored Resilience-building Intervention for Chinese American's Advance Care Planning Discussions
249. Online Exercise Program During Perioperative Treatment in Adults With Gastric Cancer
250. POP-UP: a Single-arm, Two-cohort Study: Trimodal Prehab for Upper GI and Pancreatic Cancer
251. Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
252. Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study
253. The Effect of Virtual Reality on Pain, Anxiety and Satisfaction Level Before Mammography
254. Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy
255. Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
256. The Effect of Post-operative Exercise in Gastric Cancer Patients: A Randomized Controlled Trial (RCT) Study
257. Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study
258. A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy
259. SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy
260. Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
261. Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer
262. Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver Cancer
263. A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients
264. Assessing Frailty and Its Impacts on Patients Facing Major GI Surgery
265. EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
266. Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
267. Feasibility and Effectiveness of Lymphedema Education Program After Gynecological Cancer Surgery
268. Breast Cancer - Navigate - Prospective Cohort
269. EW and Self-Guided PST in Cancer Survivors and Caregivers
270. Effects of Chiropractic on Chronic Cancer-related Fatigue
271. Evaluation of the RESTART Survival Programme
272. Different Level of ECSWT in Post Mastectomy Lymphedema
273. Acute Myocardial Infarction in Cancer Patients
274. Differences in Speed of Recovery From Anesthesia for Intraoral Surgery
275. Wound Management Following Gl Tumor Surgery: Comparing Outcomes of Dressing Changes Versus Non-Dressing Techniques
276. Telemedicine for Postoperative Follow-up After Oncological Surgeries
277. Effects of Music Therapy on Psychological States Among Cancer Patients Undergoing MRI Scans and A Relevant Mediator
278. Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
279. OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate
280. Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
281. A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer
282. Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients With Lung Cancer
283. Postoperative Complications in Cancer Patients Monitored With Intelligent Continuous Monitoring System
284. Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer
285. Impar VS Coccygeal Block in the Treatment of Coccidine
286. A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder Function
287. Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone
288. Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery
289. Personalized Live-remote Exercise Training for Cancer Survivors
290. Medical Access Program for Datopotamab Deruxtecan in NSCLC Patients
291. Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
292. Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation
293. Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer: Correlation to Therapeutic Efficacy of Cycline-Dependent Kinase Inhibitors(CDK4/6) as First Line Treatment. CYCLHER Study
294. Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.
295. Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
296. Feasibility and Benefits of Reflexology in the Prevention of Neuropathy Induced by Oxaliplatin in Colorectal Cancer
297. Hyper-ERAS Program for Highly Selective Colorectal Cancer Patients
298. Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors
299. Intestinal Akkermansia Muciniphila in Prostate Cancer
300. The HistoSonics Edisonβ„Ά System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
301. Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
302. Remote Assessment of OCT Scans for BCC Detection
303. Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial
304. Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.
305. From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy
306. Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
307. MuSK Myasthenia 1000 Study
308. Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
309. Promoting CT Engagement for Pancreatic Cancer With App
310. Observational Study Protocol: LIVER-R
311. Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward
312. The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
313. Multi-disciplinary Care for Brain Metastases
314. Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer
315. Chronic Kidney Disease Patient in Chronic Myloied Leukemia
316. The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
317. Goniometry and Goniometric Measurement on Standardised Images in Dupuytren's Disease
318. Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
319. Risk Factors for Neuroendocrine Neoplasms
320. Outcomes of Smoker and Drinker With Esophageal Squamous Cell Carcinoma After Esophagectomy
321. MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
322. Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
323. Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
324. Palliative Care Yields Cancer Wellbeing Support
325. Compare Outcomes After High and Low Ligation of Inferior Mesenteric Artery in Colorectal Cancer
326. The Effect of Mindfulness Meditation
327. Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
328. A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery
329. Laparoscopic Ultrasound Examination: Analysis of Feasibility
330. Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide
331. Resection or Ablation of Small Kidney Tumors
332. Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia
333. Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
334. Study for Wait and Watch Suitable in Rectal Cancer
335. Clinical Application of the J-PET Scanner Prototype
336. GAIN Project: Gastric Cancer and Artificial Intelligence
337. Comparing the Effectiveness of Written Vs Verbal Advice for First Degree Relatives of Colorectal Cancer Patients
338. Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer
339. Prostate Cancer Screening With PSA, Risk Calculator and Multiparametric MRI: a Pilot Study
340. A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
341. Effectiveness of NMP and TDCS vs Pharmacological Treatment in Cancer Patients With Lower Limb Pain
342. Understanding Patient Experience Among Asians at MD Anderson
343. Brain MRI Longitudinal Volumetric Characteristics Associated With Outcomes of CASPR2-Limbic Encephalitis
344. The Effect of Training Given by Whatsapp Application on Mamography Health Beliefs and Behaviors
345. Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App
346. Barriers to Cervical Cancer Screening
347. PediRISE Feasibility
348. Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
349. Coagulopathy in Childhood Acute Lymphoblastic Leukaemia
350. Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
351. Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
352. Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca
353. Effect of 3D-printed Reconstruction System in Size of Left DLT

 

Note

The above Clinical Trial information has been retrieved from ClinicalTrials.gov